These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28255009)

  • 1. Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.
    Dauriz M; Targher G; Laroche C; Temporelli PL; Ferrari R; Anker S; Coats A; Filippatos G; Crespo-Leiro M; Mebazaa A; Piepoli MF; Maggioni AP; Tavazzi L;
    Diabetes Care; 2017 May; 40(5):671-678. PubMed ID: 28255009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
    Targher G; Dauriz M; Laroche C; Temporelli PL; Hassanein M; Seferovic PM; Drozdz J; Ferrari R; Anker S; Coats A; Filippatos G; Crespo-Leiro MG; Mebazaa A; Piepoli MF; Maggioni AP; Tavazzi L;
    Eur J Heart Fail; 2017 Jan; 19(1):54-65. PubMed ID: 27790816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
    Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Crespo-Leiro MG; Anker SD; Maggioni AP; Coats AJ; Filippatos G; Ruschitzka F; Ferrari R; Piepoli MF; Delgado Jimenez JF; Metra M; Fonseca C; Hradec J; Amir O; Logeart D; Dahlström U; Merkely B; Drozdz J; Goncalvesova E; Hassanein M; Chioncel O; Lainscak M; Seferovic PM; Tousoulis D; Kavoliuniene A; Fruhwald F; Fazlibegovic E; Temizhan A; Gatzov P; Erglis A; Laroche C; Mebazaa A;
    Eur J Heart Fail; 2016 Jun; 18(6):613-25. PubMed ID: 27324686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O;
    Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL;
    Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke history predicts increased cardiovascular mortality in chronic heart failure.
    Kozdağ G; Yaymacı M; Işeri P; Ertaş G; Emre E; Bildirici U; Kılıç T; Ural D
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):421-7. PubMed ID: 21712170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.
    Rørth R; Fosbøl EL; Mogensen UM; Kragholm K; Numé AK; Gislason GH; Jhund PS; Petrie MC; McMurray JJV; Torp-Pedersen C; Køber L; Kristensen SL
    Eur J Heart Fail; 2018 Feb; 20(2):240-247. PubMed ID: 29148231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.
    Tavazzi L; Senni M; Metra M; Gorini M; Cacciatore G; Chinaglia A; Di Lenarda A; Mortara A; Oliva F; Maggioni AP;
    Circ Heart Fail; 2013 May; 6(3):473-81. PubMed ID: 23476054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
    Mantovani A; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    Metabolism; 2018 Jun; 83():205-215. PubMed ID: 29477817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure.
    Cheng YL; Sung SH; Cheng HM; Hsu PF; Guo CY; Yu WC; Chen CH
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.
    Lawson CA; Zaccardi F; McCann GP; Davies MJ; Kadam UT; Khunti K
    JAMA Netw Open; 2019 Dec; 2(12):e1916447. PubMed ID: 31790564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.